Human recombinant growth hormone ( DrugBank: Growth hormone )

---

2 diseases

ID	Disease name (Link within this page)	Number of trials
13	Multiple sclerosis/Neuromyelitis optica	1
299	Cystic fibrosis	1

13. Multiple sclerosis/Neuromyelitis optica

---

Clinical trials : 3,342 /  Drugs : 2,355 - (DrugBank : 406) / Drug target genes : 269 - Drug target pathways : 241

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2006-006465-16-DE (EUCTR)		03/05/2007	Pilot trial of recombinant human growth hormone for remyelination in multiple sclerosis - rhGH in MS	Pilot trial of recombinant human growth hormone for remyelination in multiple sclerosis - rhGH in MS	Multiple Sclerosis MedDRA version: 9.1;Level: LLT;Classification code 10063399;Term: Relapsing-remitting multiple sclerosis MedDRA version: 9.1;Classification code 10063400;Term: Secondary progressive multiple sclerosis	Trade Name: Genotropin Product Name: Genotropin INN or Proposed INN: human recombinant growth hormone	University of Leipzig	NULL	Not Recruiting			Female: yes Male: yes		Phase 2	Germany

299. Cystic fibrosis

---

Clinical trials : 1,696 /  Drugs : 1,644 - (DrugBank : 272) / Drug target genes : 96 - Drug target pathways : 170

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00005112 (ClinicalTrials.gov)	April 2000	15/4/2000	Growth Hormone Use in Cystic Fibrosis - a Multicenter Study		Cystic Fibrosis	Drug: Human recombinant growth hormone	National Center for Research Resources (NCRR)	Genentech, Inc.	Completed	5 Years	12 Years	Both		Phase 3	United States